Dynamic Monitoring of ctDNA Predicts Recurrence of Advanced Ovarian Cancer After Primary Treatments
Conditions: Ovarian Cancer Stage IV; Ovarian Cancer Stage III Intervention: Sponsors: Jing Li; Nanjing Shihejiyin Technology, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 6, 2023 Category: Research Source Type: clinical trials